Home » Topics » BioWorld Science

BioWorld Science
RSS

Penederm: Q1 1997 highlights

April 30, 1997

Centocor: Q1 1997 highlights

April 30, 1997

Genzyme Tissue Repair: Q1 1997 highlights

April 30, 1997

Astra: Q1 1997 highlights

April 30, 1997

Calcium antagonist shown to cause left ventricular hypertrophy regression

April 30, 1997

Schering-Plough develops potent farnesyltransferase inhibitor

April 30, 1997

Vertex designs potent, conformationally restricted HIV protease inhibitors

April 30, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Preclinical studies with GPI-2A reported by Genesys Pharma

April 30, 1997

New treatment for Wilson's disease now available

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...